Storys zum Thema Medizinische Behandlung

Almirall, S.A.

Almirall S.A.: Experts highlight the need to focus on psoriasis patients' wellbeing in clinical practice

Barcelona, Spain (ots/PRNewswire) - - Psoriasis affects the overall emotional wellbeing of 88% of patients[1], and at least 20% of psoriasis patients have considered suicide[2] - Currently used endpoints in psoriasis do not capture the full impact of this skin condition on patients' lives, and almost 50% of them ...

News Direct

2

#Artificial Intelligence in Healthcare - Sim&Cure Announces the Appointment of Dan Raffi as Chief Operating Officer and Board Member

Technische Universität München

Messengers from gut to brain

TECHNICAL UNIVERSITY OF MUNICHCorporate Communications Center phone: +49 89 289 22562 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/36901 High resolution images: https://mediatum.ub.tum.de/1622134 NEWS RELEASE Messengers from gut to brain Seen for the first time: T cells traveling from the gut and skin to the central nervous system Scientists have long been aware of a link between the gut ...

Almirall, S.A.

Lebrikizumab significantly improved skin clearance and itch in people with moderate-to-severe atopic deramatitis in two Phase 3 trials

Barcelona (ots/PRNewswire) - - Primary and all key secondary endpoints including itch, interference of itch on sleep and quality of life were met at Week 16 in two pivotal Phase 3 trials - Safety profile consistent with prior lebrikizumab studies in atopic dermatitis Lebrikizumab led to significant improvements with ...

Dermago GmbH

ePresentation of the results of the in-vitro study regarding the anti-proliferative and pro-apoptotic effects of Polyphenon® E (Veregen®) at the 31st German Skin Cancer Congress on 10 September 2021

Strausberg (ots) - Aresus Pharma GmbH, a company of DERMAGO Holding GmbH, announced today that the abstract "Inhibition of cell-proliferation and cell viability by Polyphenon E ® (Veregen®) in cutaneous SCC cell lines" has been accepted as an e-poster short presentation at the 31st German Skin Cancer Congress. In ...

Tianjin Haihe Media Group

2

Tianjin Haihe Media Group presents the story of Zhang Boli in fighting COVID-19 with TCM

Tianjin Haihe Media Group

Tianjin Haihe Media Group presents the story of Zhang Boli in fighting COVID-19 with TCM

News Direct

3

Vascudyne Announces Successful First Human Use of TRUE Vascular Graft for Hemodialysis Access

Technische Universität München

In many cases, MS starts long before the diagnosis

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22562 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36707/ Picture: https://mediatum.ub.tum.de/1615270 NEWS RELEASE In many cases, MS starts long before the diagnosis Multiple sclerosis is often diagnosed years after the first symptoms appear Years before they ...

Sysmex Inostics GmbH

Sysmex Inostics presents data at ASCO

Baltimore, MD (ots) - Sysmex Inostics presents data at ASCO showing HPV-SEQ, a new CLIA-validated SafeSEQ NGS HPV16/18 liquid biopsy assay, is highly effective for measuring HPV DNA in the plasma of patients with oropharyngeal squamous cell carcinoma (OPSCC) enrolled in the OPTIMA 2 treatment de-escalation trial. Sysmex Inostics, Inc., a global leader in the liquid biopsy revolution for oncology, is presenting the poster ...

BrainRepair UG

Investment breakthrough for BrainRepair UG start-up – Stem cell treatment for newborns / Dr. Metin Colpan, founder of Nasdaq listed Qiagen N.V. acquired 5% of BrainRepair UG shares worth EUR 15M

Technische Universität München

Four ERC Advanced Grants for TUM scientists

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36588/ NEWS RELEASE EU funding for cutting-edge research Four ERC Advanced Grants for TUM scientists Artificial viruses made with DNA. The human lung as a computer model. A new approach to research on diseases ...

Fördergesellschaft IZB mbH

2

Lindis Biotech develops immunotherapy against bladder cancer

Sysmex Inostics GmbH

Sysmex Inostics Presents Data at AACR Demonstrating SafeSEQ NGS Liquid Biopsy Delivers Equivalent Performance to the Extensively Clinically Validated OncoBEAM dPCR Technology for NSCLC Patients

Baltimore, MD, USA (ots) - Sysmex Inostics, Inc., a global leader of the liquid biopsy revolution for oncology, is presenting the poster “Clinical evaluation of NGS-based liquid biopsy testing in non-small cell lung cancer (NSCLC) patients” at the 112th Annual Meeting of the American Association for Cancer ...

DocMorris Adipositas Care

Introducing DocMorris Adipositas Care (Obesity Care), a digital hub empowering people with obesity to find relevant care for a better quality of life

Berlin (ots) - The Novo Nordisk and Zur Rose Group collaboration presents DocMorris Adipositas Care, a digital hub which provides people living with obesity a new way to find the right care. Adipositas Care thoughtfully empowers people living with obesity by enabling them to learn about obesity and discover possible ...

DAS Environmental Expert GmbH

German Green Technology from DAS Environmental Experts for Swiss DSM Nutritional Products AG / Moving Bed Biofilm Reactor for sustainable wastewater treatment for the food industry

Dresden (ots) - Increasing production capacities have stretched the existing wastewater treatment plant at the chemical company DSM Nutritional Products in Switzerland to its limits. Wastewater characteristics of the chemical industry with strict regulations of the beverage and food industry - the experts of German ...

Universität Mannheim

Social Stigma Burdens Innovative Lung Cancer-Therapies, Study Says

Social Stigma Burdens Innovative Lung Cancer-Therapies, Study Says Social stigma towards diseases such as lung cancer can hinder patients to seek treatment and, as a consequence, negatively affects the diffusion of innovative therapies, according to a recently published study. “Lung cancer carries a unique social stigma due to its association with cigarette smoking, and hence is often seen as a smoker’s disease, ...

DG-Nika AG

First pocket inhaler for Covid-19 and other viral mutations

Buochs (ots) - DG-Nika AG – a new approach to therapy & proactive protection from the pandemic The corona pandemic continues to pose a global threat: To date, it has been possible to vaccinate only a small fraction of the total population. On top of that, there is acute danger from mutations of this virus. Against this backdrop, the DG-Nika AG research team has developed a solution for a new approach to protecting the ...

B. Braun Melsungen AG

2

B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®

Fördergesellschaft IZB mbH

3

World Cancer Day: Start-ups at the IZB develop innovative cancer drugs and diagnostic tools

nal von minden GmbH

COVID-19: Use rapid tests to identify important biomarkers and predict the course of the disease

Moers (ots) - Whether it’s a lung embolism or a heart attack – an infection with coronavirus can have life-threatening consequences. But how badly will different patients be affected by COVID-19? This can be determined by certain biomarkers. nal von minden GmbH’s biomarker rapid tests from Germany deliver reliable results in just 15 minutes. An infection with ...

Technische Universität München

Breathing rate predicts therapeutic benefits for heart patients

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36385/ NEWS RELEASE Discovering a forgotten biosignal Breathing rate predicts therapeutic benefits for heart patients Conditions causing arrhythmia are among ...

Sysmex Inostics GmbH

Sysmex Inostics Presents Data at the American Society of Hematology Annual Meeting Demonstrating Exquisite Sensitivity of SafeSEQ NGS Technology for Detection of Measurable Residual Disease in Acute Myeloid Leukemia

Baltimore, MD (ots) - Sysmex Inostics, Inc., a global leader and pioneer in blood-based, high-sensitivity molecular testing for oncology, is presenting the poster "Ultrasensitive Measurable Residual Disease (MRD) Detection in Acute Myeloid Leukemia (AML) Using a Targeted Next Generation Sequencing (NGS) Panel" at ...

Technische Universität München

WHO guidelines on physical activity call for more exercise

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.sg.tum.de/en/news-en/news-singleview-fakultaet-en/article/prof-oberhoffer-fritz-fordert-nach-aktuellen-who-empfehlungen-kinder-und-jugendliche-muessen-sich-en/ High resolution images: https://mediatum.ub.tum.de/1581167 NEWS RELEASE WHO guidelines on physical ...